Success through development of breakthrough therapies.
Heart failure management represents one of the major challenges in medicine and health care today. Heart failure affects up to 4% of the adult population and up to 20% of the rapidly increasing population >65 years of age. To improve outcomes for people with heart failure and shape the future of patient care.
Focused, fast moving and flexible, with patients at its heart, Cardiorentis AG is committed to bringing novel therapies to the treatment of heart failure and related cardiovascular diseases. We aim to do this by:
Focusing on acute cardiovascular indications and their long-term treatment
Developing the first therapy with proven outcome benefits for patients with acute heart failure
Growing our partnerships with academic researchers, universities and practicing clinicians across the world to help drive important cardiovascular research and clinical trials forward
Making a difference in life threatening diseases